Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 63

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria

Vishnepolsky, Boris, Zaalishvili, George, Karapetian, Margarita, Nasrashvili, Tornike, Kuljanishvili, Nato, Gabrielian, Andrei, Rosenthal, Alex, Hurt, Darrell E., Tartakovsky, Michael, Grigolava, Maya, Pirtskhalava, Malak·2019·Pharmaceuticals

Abstract

Antimicrobial peptides (AMPs) have been identified as a potentially new class of antibiotics to combat bacterial resistance to conventional drugs. The design of de novo AMPs with high therapeutic indexes, low cost of synthesis, high resistance to proteases and high bioavailability remains a challenge. Such design requires computational modeling of antimicrobial properties. Currently, most computational methods cannot accurately calculate antimicrobial potency against particular strains of bacterial pathogens. We developed a tool for AMP prediction (Special Prediction (SP) tool) and made it available on our Web site (https://dbaasp.org/prediction). Based on this tool, a simple algorithm for the design of de novo AMPs (DSP) was created. We used DSP to design short peptides with high therapeutic indexes against gram-negative bacteria. The predicted peptides have been synthesized and tested in vitro against a panel of gram-negative bacteria, including drug resistant ones. Predicted activity against Escherichia coli ATCC 25922 was experimentally confirmed for 14 out of 15 peptides. Further improvements for designed peptides included the synthesis of D-enantiomers, which are traditionally used to increase resistance against proteases. One synthetic D-peptide (SP15D) possesses one of the lowest values of minimum inhibitory concentration (MIC) among all DBAASP database short peptides at the time of the submission of this article, while being highly stable against proteases and having a high therapeutic index. The mode of anti-bacterial action, assessed by fluorescence microscopy, shows that SP15D acts similarly to cell penetrating peptides. SP15D can be considered a promising candidate for the development of peptide antibiotics. We plan further exploratory studies with the SP tool, aiming at finding peptides which are active against other pathogenic organisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ph12020082

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 72

  1. Masi, 2005, Inhibitors of efflux pumps in Gram-negative bacteria, Trends Mol. Med., 11, 382, 10.1016/j.molmed.2005.06.006 · DOI · Paper page
  2. Pirtskhalava, 2016, DBAASP v.2: An Enhanced Database of Structure and Antimicrobial/Cytotoxic Activity of Natural and Synthetic Peptides, Nucl. Acids Res., 44, D1104, 10.1093/nar/gkv1174 · DOI · Paper page
  3. Greber, 2017, Antimicrobial Peptides Under Clinical Trials, Curr. Top. Med. Chem., 17, 620, 10.2174/1568026616666160713143331 · DOI · Paper page
  4. Li, 2017, Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design, Front. Neurosci., 11, 73, 10.3389/fnins.2017.00073 · DOI · Paper page
  5. Grieco, 2011, Alanine scanning analysis and structure–function relationships of the frog-skin antimicrobial peptide temporin-1Ta, J. Pept. Sci., 17, 358, 10.1002/psc.1350 · DOI
  6. Rausch, 2013, Alanine scan of the peptide antibiotic feglymycin: Assessment of amino acid side chains contributing to antimicrobial activity, ChemBioChem, 14, 625, 10.1002/cbic.201300032 · DOI
  7. Fjell, 2011, Designing Antimicrobial Peptides: Form Follows Function, Nat. Rev. Drug Discov., 11, 37, 10.1038/nrd3591 · DOI · Paper page
  8. Torrent, 2012, AMPA: An Automated Web Server for Prediction of Protein Antimicrobial Regions, Bioinformatics, 28, 130, 10.1093/bioinformatics/btr604 · DOI · Paper page
  9. Jenssen, 2007, Evaluating Different Descriptors for Model Design of Antimicrobial Peptides with Enhanced Activity toward P. aeruginosa, Chem. Biol. Drug. Des., 70, 134, 10.1111/j.1747-0285.2007.00543.x · DOI
  10. Taboureau, 2006, Design of Novispirin Antimicrobial Peptides by Quantitative Structure-Activity Relationship, Chem. Biol. Drug Des., 68, 48, 10.1111/j.1747-0285.2006.00405.x · DOI
  11. Wang, 2016, Spontaneous formation of structurally diverse membrane channel architectures from a single antimicrobial peptide, Nat. Commun., 7, 13535, 10.1038/ncomms13535 · DOI
  12. Li, 2015, A novel fragment based strategy for membrane active antimicrobials against MRSA, Biochim. Biophys. Acta Biomembr., 1848, 1023, 10.1016/j.bbamem.2015.01.001 · DOI
  13. Li, 2013, Molecular simulations suggest how a branched antimicrobial peptide perturbs a bacterial membrane and enhances permeability, Biochim. Biophys. Acta Biomembr., 1828, 1112, 10.1016/j.bbamem.2012.12.015 · DOI
  14. Fox, 2016, The multifaceted roles of molecular dynamics simulations in drug discovery, Curr. Pharm. Des., 22, 3585, 10.2174/1381612822666160425120507 · doi:10.2174/1381612822666160425120507
  15. Saravanan, 2014, Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility, Biotechnol. Bioeng., 111, 37, 10.1002/bit.25003 · DOI
  16. Mohanram, 2014, b-boomerang antimicrobial and antiendotoxic peptides: Lipidation and disulfide bond effects on activity and structure, Pharmaceuticals, 7, 482, 10.3390/ph7040482 · doi:10.3390/ph7040482
  17. Jeong, 2016, NMR structural studies of antimicrobial peptides: LPcin analogs, Biophys. J., 110, 423, 10.1016/j.bpj.2015.12.006 · doi:10.1016/j.bpj.2015.12.006
  18. Jenssen, 2008, QSAR Modeling and Computer-Aided Design of Antimicrobial Peptides, J. Pept. Sci., 14, 110, 10.1002/psc.908 · DOI
  19. Fjell, 2009, Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning, J. Med. Chem., 52, 2006, 10.1021/jm8015365 · DOI · Paper page
  20. Cherkasov, 2009, Use of Artificial Intelligence in the Design of Small Peptide Antibiotics Effective against a Broad Spectrum of Highly Antibiotic-Resistant Superbugs, ACS Chem. Biol., 4, 65, 10.1021/cb800240j · DOI · Paper page
  21. Torrent, M., Andreu, D., Nogues, V.M., and Boix, E. (2011). Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model. PLoS ONE, 6. · DOI · Paper page
  22. Mooney, 2013, Peptidelocator: Prediction of Bioactive Peptides in Protein Sequences, Bioinformatics, 29, 1120, 10.1093/bioinformatics/btt103 · DOI
  23. Porto, W.F., Pires, A.S., and Franco, O.L. (2012). Cs-Amppred: An Updated SVM Model for Antimicrobial Activity Prediction in Cysteine-Stabilized Peptides. PLoS ONE, 7. · DOI
  24. Ng, 2015, Prediction of Antimicrobial Peptides Based on Sequence Alignment and Support Vector Machine-Pairwise Algorithm Utilizing LZ-Complexity, Biomed. Res. Int., 2015, 212715, 10.1155/2015/212715 · DOI
  25. Khosravian, 2013, Predicting Antibacterial Peptides by the Concept of Chou’s Pseudo-Amino Acid Composition and Machine Learning Methods, Protein Pept. Lett., 20, 180, 10.2174/092986613804725307 · doi:10.2174/092986613804725307
  26. Meher, 2017, Predicting Antimicrobial Peptides with Improved Accuracy by Incorporating the Compositional, Physico-Chemical and Structural Features into Chou’s General PseAAC, Sci. Rep., 7, 42362, 10.1038/srep42362 · DOI · Paper page
  27. Lira, 2013, Prediction of Antimicrobial Activity of Synthetic Peptides by a Decision Tree Model, Appl. Environ. Microbiol., 79, 3156, 10.1128/AEM.02804-12 · doi:10.1128/aem.02804-12
  28. Khamis, 2015, Distinct Profiling of Antimicrobial Peptide Families, Bioinformatics, 31, 849, 10.1093/bioinformatics/btu738 · DOI
  29. Xiao, 2013, Iamp-2l: A Two-Level Multi-Label Classifier for Identifying Antimicrobial Peptides and Their Functional Types, Anal. Biochem., 436, 168, 10.1016/j.ab.2013.01.019 · DOI · Paper page
  30. Maccari, G., Di Luca, M., Nifosí, R., Cardarelli, F., Signore, G., Boccardi, C., and Bifone, A. (2013). Antimicrobial Peptides Design by Evolutionary Multiobjective Optimization. PLoS Comput. Biol., 9. · DOI
  31. Bhadra, 2018, AmPEP: Sequence-based Prediction of Antimicrobial Peptides using Distribution Patterns of Amino Acid Properties and Random Forest, Sci. Rep., 8, 1697, 10.1038/s41598-018-19752-w · DOI · Paper page
  32. Youmans, M., Spainhour, C., and Qiu, P. (2017, January 13–16). Long Short-Term Memory Recurrent Neural Networks for Antibacterial Peptide Identification. Proceedings of the 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Kansas City, MO, USA. · DOI
  33. Juretic, 2009, Computational Design of Highly Selective Antimicrobial Peptides, J. Chem. Inf. Model., 49, 2873, 10.1021/ci900327a · DOI
  34. Wang, P., Hu, L., Liu, G., Jiang, N., Chen, X., Xu, J., Zheng, W., Li, L., Tan, M., and Chen, Z. (2011). Prediction of Antimicrobial Peptides Based on Sequence Alignment and Feature Selection Methods. PLoS ONE, 6. · DOI · Paper page
  35. Melo, M.N., Ferre, R., Feliu, L., Bardaji, E., Planas, M., and Castanho, M.A. (2011). Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides. PLoS ONE, 6. · DOI
  36. Freire, 2015, Mining Viral Proteins for Antimicrobial and Cell-Penetrating Drug Delivery Peptides, Bioinformatics, 31, 2252, 10.1093/bioinformatics/btv131 · DOI
  37. Chang, K.Y., Lin, T.P., Shih, L.Y., and Wang, C.K. (2015). Analysis and Prediction of the Critical Regions of Antimicrobial Peptides Based on Conditional Random Fields. PLoS ONE, 10. · DOI
  38. Toropova, 2015, QSAR Modeling of the Antimicrobial Activity of Peptides as a Mathematical Function of a Sequence of Amino Acids, Comput. Biol. Chem., 59, 126, 10.1016/j.compbiolchem.2015.09.009 · DOI
  39. Toropov, 2012, QSAR Modeling of Endpoints for Peptides Which Is Based on Representation of the Molecular Structure by a Sequence of Amino Acids, Struct. Chem., 23, 1891, 10.1007/s11224-012-9995-0 · DOI
  40. Lata, S., Sharma, B.K., and Raghava, G.P. (2007). Analysis and Prediction of Antibacterial Peptides. BMC Bioinf., 8. · DOI · Paper page
  41. Lata, S., Mishra, N.K., and Raghava, G.P. (2010). AntiBP2: Improved Version of Antibacterial Peptide Prediction. BMC Bioinf., 11. · DOI · Paper page
  42. Nagarajan, 2018, Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria, J. Biol. Chem., 293, 3492, 10.1074/jbc.M117.805499 · DOI
  43. Giraldo, 2018, In silico design of polycationic antimicrobial peptides active against Pseudomonas aeruginosa and Staphylococcus aureus, Antonie Van Leeuwenhoek, 111, 1871, 10.1007/s10482-018-1080-2 · DOI
  44. Vishnepolsky, 2018, Predictive model of linear AMPs active against Gram-negative bacteria, J. Chem. Inf. Model., 58, 1141, 10.1021/acs.jcim.8b00118 · DOI
  45. Vishnepolsky, B., and Pirtskhalava, M. (2019). Comment on: ‘Empirical Comparison of Web-Based Antimicrobial Peptide Prediction Tools’. Bioinformatics. · DOI
  46. Vishnepolsky, 2014, Prediction of Linear Cationic Antimicrobial Peptides Based on Characteristics Responsible for Their Interaction with the Membranes, J. Chem. Inf. Model., 54, 1512, 10.1021/ci4007003 · DOI
  47. Nicolau, 2008, Carbapenems: A potent class of antibiotics, Expert Opin. Pharm., 9, 23, 10.1517/14656566.9.1.23 · DOI · Paper page
  48. Holton, 2013, CPPpred: Prediction of cell penetrating peptides, Bioinformatics, 29, 3094, 10.1093/bioinformatics/btt518 · DOI · Paper page
  49. Matsuzaki, 1999, Why and how are peptide–lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes, Biochim. Biophys. Acta (BBA) Biomembr., 1462, 1, 10.1016/S0005-2736(99)00197-2 · DOI · Paper page
  50. Shai, 1999, Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides, Biochim. Biophys. Acta (BBA) Biomembr., 1462, 55, 10.1016/S0005-2736(99)00200-X · DOI · Paper page
  51. Yang, 2000, Crystallization of antimicrobial pores in membranes: Mgainin and ptegrin, Biophys. J., 79, 2002, 10.1016/S0006-3495(00)76448-4 · DOI · Paper page
  52. Brogden, 2005, Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?, Nat. Rev. Microbiol., 3, 238, 10.1038/nrmicro1098 · DOI · Paper page
  53. Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 · DOI · Paper page
  54. Reddy, 2004, Antimicrobial peptides: Premises and promises, Int. J. Antimicrob. Agents, 24, 536, 10.1016/j.ijantimicag.2004.09.005 · DOI · Paper page
  55. Otvos, 2000, Antibacterial peptides isolated from insects, J. Pept. Sci., 6, 497, 10.1002/1099-1387(200010)6:10<497::AID-PSC277>3.0.CO;2-W · DOI · Paper page
  56. Bierbaum, 1998, The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II, Antimicrob. Agents Chemother., 42, 154, 10.1128/AAC.42.1.154 · DOI · Paper page
  57. Matsuzaki, 1998, Relationship of membrane curvature to the formation of pores by magainin 2, Biochemistry, 37, 11856, 10.1021/bi980539y · DOI · Paper page
  58. Dagan, 2002, In vitro antiplasmodium effects of dermaseptin S4 derivatives, Antimicrob. Agents Chemother., 46, 1059, 10.1128/AAC.46.4.1059-1066.2002 · DOI
  59. Matsuzaki, 1996, An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation, Biochemistry, 35, 11361, 10.1021/bi960016v · DOI · Paper page
  60. Wu, 1999, Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli, Biochemistry, 38, 7235, 10.1021/bi9826299 · DOI · Paper page
  61. Martins, 2018, Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides, Nat. Microbiol., 3, 718, 10.1038/s41564-018-0164-0 · DOI · Paper page
  62. Shagaghi, 2017, Revealing the sequence of interactions of PuroA peptide with Candida albicans cells by live-cell imaging, Sci. Rep., 7, 43542, 10.1038/srep43542 · DOI
  63. Chan, 2006, Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action, Biochim. Biophys. Acta (BBA) Biomembr., 758, 1184, 10.1016/j.bbamem.2006.04.006 · DOI · Paper page
  64. Patrzykat, 2002, Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli, Antimicrob. Agents Chemother., 46, 605, 10.1128/AAC.46.3.605-614.2002 · DOI · Paper page
  65. Ester, M., Kriegel, H., Sander, J., and Xu, X. (1996, January 2–4). A density-based algorithm for discovering clusters in large spatial databases with noise. Proceedings of the Second International Conference on Knowledge Discovery and Data Mining (KDD-96), Portland, Oregon.
  66. Moon, 2011, Side-chain hydrophobicity scale derived from transmembrane protein folding into lipid bilayers, Proc. Natl. Acad. Sci. USA, 108, 10174, 10.1073/pnas.1103979108 · DOI · Paper page
  67. Senes, 2007, E(z), a Depth-dependent Potential for Assessing the Energies of Insertion of Amino Acid Side-chains into Membranes: Derivation and Applications to Determining the Orientation of Transmembrane and Interfacial Helices, J. Mol. Biol., 366, 436, 10.1016/j.jmb.2006.09.020 · DOI · Paper page
  68. Uversky, 2000, Why are “natively unfolded” proteins unstructured under physiological conditions?, Proteins Struct. Funct. Gen., 41, 415, 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7 · DOI · Paper page
  69. Kessel, A., and Ben-Tal, N. (2011). Introduction to Proteins: Structure, Function and Motion (Chapman & Hall/CRC Mathematical and Computational Biology), CRC Press, Taylor & Francis Group. [1st ed.].
  70. The UniProt Consortium (2015). UniProt: A hub for protein information. Nucleic Acids Res., 43, D204–D212. · DOI · Paper page
  71. Wang, 2016, APD3: The antimicrobial peptide database as a tool for research and education, Nucleic Acids Res., 44, D1087, 10.1093/nar/gkv1278 · DOI · Paper page
  72. Fan, 2016, DRAMP: A comprehensive data repository of antimicrobial peptides, Sci. Rep., 14, 24482, 10.1038/srep24482 · DOI · Paper page

Cited by

See all 63

Metadata

Authors
Vishnepolsky, B., Zaalishvili, G., Karapetian, M., Nasrashvili, T., Kuljanishvili, N., Gabrielian, A., Rosenthal, A., Hurt, D. E., Tartakovsky, M., Grigolava, M., & Pirtskhalava, M.
Venue
Pharmaceuticals
Publisher
MDPI AG
Published
2019-06-03
Volume
12
Issue
2
Pages
82
ISSN
1424-8247
Cited by
63
References
2
Language
en
Funders
International Science and Technology Center (G-2102)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria. https://app.cochat.ai/papers/10.3390/ph12020082
The paper
Vishnepolsky, B., Zaalishvili, G., Karapetian, M., Nasrashvili, T., Kuljanishvili, N., Gabrielian, A., Rosenthal, A., Hurt, D. E., Tartakovsky, M., Grigolava, M., & Pirtskhalava, M. (2019). De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria. Pharmaceuticals. https://doi.org/10.3390/ph12020082

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.